arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

INCYTE CORP

INCY
$120.60 ▲ +2.21 (+1.87%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
18 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
86
Health
Excellent
Bullish
auto_awesome

Analytical Summary

INCYTE CORP shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $23.5B
Dividend Yield
Revenue Growth 21.2%
Op. Margin 29.5%
ROIC 22.7%
FCF / Share $7.24
Trailing P/E 18.3x
Price / Book 4.6x
FCF Yield 6.0%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.14B
↑ +21.2%
Net Income Profit after all expenses
$1.29B
↑ +3845.0%
Operating Margin Operating profit as % of sales
29.5%
↑ +1936.4% 86th
FCF / Share Free cash flow per share
$7.24
↑ +347.2%
Long-Term Debt Long-term obligations
$19.09B
↑ +71146.3%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
88
Returns
90
Cash Quality
69

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters